NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral

AI Analysis

Summary

NewAmsterdam Pharma approved inducement share options covering 28,700 ordinary shares granted to four new non-executive employees as part of its 2024 Inducement Plan under Nasdaq Listing Rule 5635(c)(4).

Importance:1/10

Sentiment:

0.00

employee compensationstock optionsinducement grantsnasdaq listing rule

Related Companies

$NAMS

Read the original article

Published by GlobeNewswire Pharma on July 2, 2026 8:01 PM

Read Original